Determining patient utility following coronary revascularization.

Area of Science:

• Cardiovascular Medicine
• Health Economics
• Patient-Reported Outcomes

Background:

• Clinical trials often focus solely on primary endpoints, potentially overlooking long-term patient benefits.
• Comparing treatments like Coronary Artery Bypass Grafting (CABG) and Percutaneous Transluminal Coronary Angioplasty (PTCA) requires assessing evolving patient utility over time.
• CABG has higher initial risks, while PTCA may lead to recurrent angina and repeat procedures.

Purpose of the Study:

• To introduce a novel survey instrument for estimating patient utility associated with CABG and PTCA.
• To provide a method for comparing the long-term value of different revascularization strategies for multivessel coronary artery disease.
• To facilitate the calculation of Quality Adjusted Life Years (QALYs) for a more comprehensive treatment assessment.

Main Methods:

• Development and validation of a patient utility survey.
• Application of the survey to patients undergoing CABG or PTCA for multivessel coronary artery disease.
• Integration of patient utility estimates with survival data to calculate Quality Adjusted Life Years (QALYs).

Main Results:

• The proposed survey effectively estimates patient-specific utility for different treatment pathways.
• Patient utility varies significantly over time for both CABG and PTCA.
• The framework allows for the calculation of QALYs, offering a more nuanced comparison of treatment benefits.

Conclusions:

• Patient utility assessment is crucial for a comprehensive comparison of CABG and PTCA.
• The developed survey provides a valuable tool for incorporating patient perspectives into treatment outcome evaluations.
• Calculating QALYs using patient utility data enhances the evidence base for decision-making in cardiovascular care.